Document Detail


Disturbed prolactin responses to dopamine-related substances in patients with acromegaly and hyperprolactinemia.
MedLine Citation:
PMID:  4042986     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We undertook this study, because conflicting data were reported about the dopaminergic regulation of prolactin (PRL) secretion in patients with acromegaly and hyperprolactinemia. In order to clarify the dopaminergic regulation of PRL secretion in patients with acromegaly and hyperprolactinemia, the effects of nomifensine, a central dopamine agonist, FK 33-824, a centrally antidopaminergically acting agent, and domperidone, a peripheral dopamine antagonist, on plasma PRL in these patients were studied. The results were compared with those observed in normal subjects and hyperprolactinemic patients, with or without a pituitary tumor. Nomifensine did not lower the PRL levels and FK 33-824 did not raise the PRL levels in acromegalic patients. In hyperprolactinemic patients, nomifensine did not lower the PRL levels and FK 33-824 failed to raise the PRL levels. Domperidone did not increase PRL in about a third of acromegalic patients, while TRH increased PRL in the all normoprolactinemic acromegalic patients. These results suggest that in acromegalic patients there may be a disturbance in dopamine related neurotransmission and that such disorders also seem to be present in patients with hyperprolactinemia, with or without a pituitary tumor.
Authors:
K Sekiya; T Karashima; S Ikuyama; K Muta; K Kato; H Ibayashi
Related Documents :
17276926 - Assessment of bilateral inferior petrosal sinus sampling (bipss) in the diagnosis of cu...
16151976 - High prevalence of abnormal circadian blood pressure regulation and impaired glucose to...
6316866 - Normal cortisol response to corticotropin in patients with secondary adrenal failure.
17542196 - Treatment of acute adrenal insufficiency.
12435296 - Diagnosis of interstitial lung disease in patients with connective tissue disease by th...
25274586 - Dermatoglyphic features in patients with multiple sclerosis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Endocrinologia japonica     Volume:  32     ISSN:  0013-7219     ISO Abbreviation:  Endocrinol. Jpn.     Publication Date:  1985 Apr 
Date Detail:
Created Date:  1985-10-31     Completed Date:  1985-10-31     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376546     Medline TA:  Endocrinol Jpn     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  207-14     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acromegaly / blood*
Adult
D-Ala(2),MePhe(4),Met(0)-ol-enkephalin / pharmacology*
Domperidone / pharmacology
Female
Humans
Male
Middle Aged
Nomifensine / pharmacology*
Pituitary Neoplasms / blood
Prolactin / blood*
Radioimmunoassay
Chemical
Reg. No./Substance:
24526-64-5/Nomifensine; 57808-66-9/Domperidone; 64854-64-4/D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; 9002-62-4/Prolactin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inhibition of rat uterine gland genesis by tamoxifen.
Next Document:  Effect of colchicine on the depletion and replenishment of cytoplasmic glucocorticoid receptor in ra...